Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprises is currently trading at Rs. 1132.20, up by 6.00 points or 0.53% from its previous closing of Rs. 1126.20 on the BSE.

The scrip opened at Rs. 1126.00 and has touched a high and low of Rs. 1139.90 and Rs. 1125.80 respectively. So far 1,606 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1242.75 on 20-Nov-2014 and a 52 week low of Rs. 852.50 on 11-Mar-2014.

Last one week high and low of the scrip stood at Rs. 1151.00 and Rs. 1119.00 respectively. The current market cap of the company is Rs. 15,751.00 crore.

The promoters holding in the company stood at 34.35% while Institutions and Non-Institutions held 45.79% and 19.11% respectively.

By launching a new department of gastro sciences and increasing the capacity of the cancer treatment facility, Apollo Gleneagles Hospitals, a joint venture (JV) of Apollo Hospital Enterprises, is planning to add 170 more beds this year. With the addition of 170 beds this year, Apollo will thus become a 780-bed multi-speciality tertiary care hospital.

Besides, with the launch of mobile app ‘Happ’, Apollo is looking at strengthening telemedicine not only in eastern India but also in the eastern part of the world in countries such as Bangladesh, Myanmar, Nepal and Bhutan.

Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.